share_log

Morgan Stanley Maintains Equal-Weight on Anterix, Lowers Price Target to $41

Benzinga ·  Aug 1, 2023 10:39

Morgan Stanley analyst Nigel Dally maintains Anterix (NASDAQ:ATEX) with a Equal-Weight and lowers the price target from $42 to $41.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment